Showing results (111-120 of 181) with videos related to

Sort By:
Pageof 19
Neurology|November 19, 2016
Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetilSamuel Bitoun, Diane Bouvry, Raphaël Borie, et al.
Blood Advances|September 30, 2024
Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficienciesMargaux Soulard, Lionel Galicier, Nizar Mahlaoui, et al.
Rheumatology (Oxford, England)|May 15, 2018
Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonistsZelie Guitton, Louis Terriou, Jean-Christophe Lega, et al.
American Journal of Hematology|October 7, 2025
Efficacy and Thrombotic Risk of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia Secondary to Systemic Lupus and Antiphospholipid Syndrome: French Experience With 80 PatientsCindy Marques, Guillaume Moulis, Mickaël Roussotte, et al.
Medicine|June 23, 2011
Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patientsMatthieu Mahévas, Laurent Chiche, Yurdagul Uzunhan, et al.
Haematologica|August 21, 2020
Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase 2b trialMatthieu Mahévas, Imane Azzaoui, Etienne Crickx, et al.
British Journal of Haematology|October 11, 2011
Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patientsDelphine Gobert, James B Bussel, Charlotte Cunningham-Rundles, et al.
Clinical Immunology (Orlando, Fla.)|April 15, 2020
Utilization of intravenous or subcutaneous immunoglobulins in secondary immune deficiency (ULTIMATE): A retrospective multicenter studyPaul Legendre, Doumit Chahwan, Zora Marjanovic, et al.
Science Translational Medicine|April 15, 2021
Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopeniaEtienne Crickx, Pascal Chappert, Aurélien Sokal, et al.
Blood|May 9, 2012
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopeniaVivek L Patel, Matthieu Mahévas, Soo Y Lee, et al.
Pageof 19